Abbott Laboratories
ABT · NYSE
- $107.81
- $187.95B
- Open
- —
- —
- $0.00 - $0.00
- $81.97 - $137.49
- —
- —
- 5.60M
About Abbott Laboratories
Abbott Laboratories is a diversified healthcare company that sells products in diagnostics, medical devices, and nutrition. It makes money by selling those products across its portfolio rather than relying on a single healthcare category, and the supplied material says its medical-device and diagnostics portfolio was recently bolstered by the acquisition of Exact Sciences. The evidence does not quantify revenue contributions by segment or identify customer groups beyond the healthcare market. Abbott reported $44.3 billion of FY2025 revenue and $6.5 billion of net income, establishing its current multibillion-dollar scale.
Notable Price Movement
- Aug 3-7$107.812.00%
Abbott shares fell 1.69% over the week, from $107.27 to $105.46. Trading was choppy: the stock rose to $108.00 on July 29, then dropped to $105.61 on July 30, was little changed July 31, rebounded to $107.12 on August 3, and gave back that recovery with a 1.55% decline on August 4. The supplied evidence contains no Abbott-specific announcement, earnings update, analyst action, or guidance change explaining the move. It also provides no broader market or sector catalyst; therefore, the weekly decline is best characterized as trading without an identified company-specific driver.
